CLINICAL_TRIALS
trial_result
· 2016-12-02
Clinical Trial Update: Ciclesonide for the Treatment of Airway Hyperresponsiveness [Phase 4]
Summary
A Phase 4 trial evaluating ciclesonide for airway hyperresponsiveness in asthma has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: AstraZeneca | Conditions: Asthma | Phase 4 | Status: COMPLETED